19 May 2013
Keywords: AstraZeneca, CrystalGenomics, Anti-infectives, AC Immune, Alzheimer's Moscow University, Licensing, Morphomer
Article | 14 January 2010
Anglo-Swedish drug major AstraZeneca has entered into a research collaboration with South Korea-based CrystalGenomics to discover and develop a novel ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.